Literature DB >> 2126946

The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.

P Crawford1, D J Chadwick, C Martin, J Tjia, D J Back, M Orme.   

Abstract

Patients taking oral contraceptive steroids (OCS) are known to suffer contraceptive failure while taking anticonvulsants such as phenobarbitone, phenytoin and carbamazepine. We have studied the single dose kinetics of ethinyloestradiol (EE2); 50 micrograms, and levonorgestrel (Ng); 250 micrograms in groups of women before and 8-12 weeks after starting therapy with phenytoin (n = 6) and carbamazepine (n = 4). The area under the plasma concentration-time curve (AUC) was measured over a 24 h period for each steroid and significant reductions were seen with both anticonvulsants. Phenytoin reduced the AUC for EE2 from 806 +/- 50 (mean +/- s.d.) to 411 +/- 132 pg ml-1 h (P less than 0.05) and for Ng from 33.6 +/- 7.8 to 19.5 +/- 3.8 ng ml-1 h (P less than 0.05). Carbamazepine reduced the AUC for EE2 from 1163 +/- 466 to 672 +/- 211 pg ml-1 h (P less than 0.05) and for Ng from 22.9 +/- 9.4 to 13.8 +/- 5.8 ng ml-1 h (P less than 0.05). These changes are compatible with the known enzyme inducing effects of phenytoin and carbamazepine. Patients taking these anticonvulsants will need to be given increased doses of OCS (equivalent to 50-100 micrograms EE2 daily) to achieve adequate contraceptive effects.

Entities:  

Keywords:  Contraception; Contraception Failure; Contraceptive Agents, Estrogen--pharmacodynamics; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents--pharmacodynamics; Contraceptive Methods--pharmacodynamics; Contraceptive Usage; Drug Interactions; Drugs; Ethinyl Estradiol--pharmacodynamics; Examinations And Diagnoses; Family Planning; Laboratory Examinations And Diagnoses; Levonorgestrel--pharmacodynamics; Oral Contraceptives--pharmacodynamics; Treatment

Mesh:

Substances:

Year:  1990        PMID: 2126946      PMCID: PMC1368312          DOI: 10.1111/j.1365-2125.1990.tb05457.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids.

Authors:  P Crawford; D Chadwick; P Cleland; J Tjia; A Cowie; D J Back; M L Orme
Journal:  Contraception       Date:  1986-01       Impact factor: 3.375

2.  Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics.

Authors:  D J Back; S F Grimmer; M L Orme; C Proudlove; R D Mann; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

3.  Pharmacological implications of microsomal enzyme induction.

Authors:  A H Conney
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

4.  Unplanned pregnancy in an epileptic.

Authors:  I E Kenyon
Journal:  Br Med J       Date:  1972-03-11

Review 5.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

6.  The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy.

Authors:  D J Back; M Bates; A Bowden; A M Breckenridge; M J Hall; H Jones; M MacIver; M Orme; E Perucca; A Richens; P H Rowe; E Smith
Journal:  Contraception       Date:  1980-11       Impact factor: 3.375

Review 7.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

8.  The pharmacokinetics of levonorgestrel and ethynylestradiol in women - studies with Ovran and Ovranette.

Authors:  D J Back; M Bates; A M Breckenridge; J M Hall; M MacIver; M L Orme; B K Park; P H Rowe
Journal:  Contraception       Date:  1981-03       Impact factor: 3.375

9.  Do anticonvulsants reduce the efficacy of oral contraceptives?

Authors:  C B Coulam; J F Annegers
Journal:  Epilepsia       Date:  1979-10       Impact factor: 5.864

10.  An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.

Authors:  D J Back; A M Breckenridge; F E Crawford; M MacIver; M L Orme; P H Rowe; M J Watts
Journal:  Contraception       Date:  1979-09       Impact factor: 3.375

  10 in total
  38 in total

Review 1.  Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants.

Authors:  K Wilbur; M H Ensom
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

2.  Anti-epileptic drugs and hormonal treatments.

Authors:  Clare A Johnston; Pamela M Crawford
Journal:  Curr Treat Options Neurol       Date:  2014-05       Impact factor: 3.598

3.  Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes.

Authors:  A P Li; N R Hartman; C Lu; J M Collins; J M Strong
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

4.  The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.

Authors:  Jagdev Sidhu; Sarah Job; Sunita Singh; Richard Philipson
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

5.  Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.

Authors:  D Ouellet; A Hsu; J Qian; C S Locke; C J Eason; J H Cavanaugh; J M Leonard; G R Granneman
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

Review 6.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 7.  Pharmacokinetics of haloperidol: an update.

Authors:  S Kudo; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 8.  Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy.

Authors:  Jouko I T Isojärvi; Erik Taubøll; Andrew G Herzog
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

9.  Do oral contraceptives increase epileptic seizures?

Authors:  Doodipala Samba Reddy
Journal:  Expert Rev Neurother       Date:  2016-10-12       Impact factor: 4.618

Review 10.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.